IDiyas

For the Inventor, By the Inventor

Portola Valley, CA, United States of America

Peter Virsik

USPTO Granted Patents = 21 

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 186(Granted Patents)


Company Filing History:

goldMedal10 out of 142 
 
Xenoport, Inc.
 patents
silverMedal7 out of 7 
 
Essa Pharma, Inc.
 patents
bronzeMedal3 out of 932 
 
University of British Columbia
 patents
4. 3 out of 23 
 
Provincial Health Services Authority
 patents
5. 3 out of 20 
 
Arbor Pharmaceuticals, LLC
 patents
6. 1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...
21 patents (USPTO):Explore Patents
1. 12109179 - Pharmaceutical compositions and combinations comprising inhibitors of the androgen receptor and uses thereof (2024-10-08),
2. 11814357 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2023-11-14),
3. 11518747 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2022-12-06),
4. 11485713 - Androgen receptor modulators and methods for their use (2022-11-01),
5. 11358938 - Solid forms of an N-terminal domain androgen receptor inhibitor and uses thereof (2022-06-14),
6. 11242324 - Solid forms of an n-terminal domain androgen receptor inhibitor and uses thereof (2022-02-08),
7. 11059795 - Androgen receptor modulators and methods for their use (2021-07-13),
8. 10945984 - Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects (2021-03-16),
9. 10940117 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2021-03-09),
10. 10716760 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2020-07-21),
11. 10624340 - Chemical combinations for attracting Vespidae (2020-04-21),
12. 9597292 - Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof (2017-03-21),
13. 9452972 - Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof (2016-09-27),
14. 8785443 - Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof (2014-07-22),
15. 8778991 - Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use (2014-07-15),

Title: Peter Virsik – Innovator in Pharmaceutical Compositions

Introduction

Peter Virsik, located in Portola Valley, California, is an accomplished inventor with a remarkable portfolio of 21 patents. His work primarily focuses on pharmaceutical compositions and their applications, particularly in the field of oncology. This article delves into his most recent patents, career milestones, and collaborations with other notable professionals in the industry.

Latest Patents

Peter Virsik's latest innovations include groundbreaking patents that provide insights into pharmaceutical compositions comprising inhibitors of the androgen receptor. One such patent discusses the use of an androgen receptor N-terminal domain inhibitor in combination with other therapeutic agents, offering promising treatment options for various cancers, including breast and prostate cancer. Moreover, another significant patent highlights a crystalline and amorphous form of Compound I, which is aimed at enhancing the efficacy of treatment with these inhibitors. Together, these patents showcase his commitment to advancing cancer therapies and improving patient outcomes.

Career Highlights

Throughout his career, Peter has made significant contributions to the pharmaceutical sector. He has worked with notable companies like Xenoport, Inc. and Essa Pharma, Inc., where he applied his expertise in drug development to create innovative solutions. His extensive experience in the industry has equipped him with the necessary skills to tackle complex challenges in pharmaceutical research and development.

Collaborations

In his professional journey, Peter has collaborated with accomplished colleagues such as Han-Jie Zhou and Noa Zerangue. These partnerships have fostered an environment of innovation, enabling the cross-pollination of ideas and techniques essential for breakthrough discoveries in the pharmaceutical landscape.

Conclusion

Peter Virsik stands out as a prominent inventor in the field of pharmaceutical compositions, particularly in developing treatments for cancers. His extensive patent portfolio and collaborations with industry leaders reflect a dedication to enhancing therapeutic options for patients. As the pharmaceutical industry continues to evolve, Peter's work will undoubtedly play a pivotal role in shaping the future of cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…